Advocacy intelligence hub — real-time data for patient organizations
City of Hope Medical Center — PHASE2
Eli Lilly and Company — PHASE1
University of Pennsylvania — PHASE1
Joseph Tuscano — PHASE2
GenomeFrontier Therapeutics TW Co., Ltd. — PHASE1
Sana Biotechnology — PHASE1
Shanghai Ming Ju Biotechnology Co., Ltd.
Peking University — PHASE2
Tianjin Medical University Cancer Institute and Hospital — PHASE3
Sun Yat-sen University — PHASE2
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Browse all Nodal T-follicular helper cell lymphoma, follicular type news →
Leona Holmberg
Fred Hutch/University of Washington Cancer Consortium
📍 SEATTLE, WA
Suresh Mahabhashyam, MD, MPH
Corvus Pharmaceuticals, Inc.
Dehui Zou, Dr.
Institute of Hematology & Blood Diseases Hospital, China
Sonali Smith
University of Chicago
📍 CHICAGO, IL
Bistol-Myers Squibb
Bristol-Myers Squibb
Paolo Corradini, Prof
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano
View all Nodal T-follicular helper cell lymphoma, follicular type specialists →